Digene To Pay $3.5M Over 13 Months In License Pact
Under the terms of the agreement, Digene received a nonexclusive sublicense to a U.S. patent, as well as its foreign counterparts, known as the Caskey patents. Additional payments to Abbott Labs will be due as certain products come to market.
The company entered into the agreement with Abbott Labs on June 30, according to...
To view the full article, register now.